Associations between disease exacerbation following SARS-CoV-2 vaccinations and age, gender, immunomodulating treatment and disability level among German people with multiple sclerosis.
This figure shows the results of a multivariable logistic regression model regarding the associations between worsened/new-onset MS symptoms and sociodemographic, clinical as well as therapeutic patient characteristics. The small, black-framed boxes show the values of the odds ratios on the x-axis. The whiskers emanating from the boxes enclose the 95% confidence interval of the odds ratios. Significant associations were represented by blue (following the first vaccination) and yellow markers (following the second vaccination).
CI – confidence interval
DMD – disease-modifying drug
MS – multiple sclerosis
Ref – reference
SARS-CoV-2 – severe acute respiratory syndrome coronavirus 2.